Hemogenyx Pharmaceuticals PLC Announces Interim Results for the Period Ended 30 June 2020
LONDON, UK / ACCESSWIRE / September 30, 2020 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the Standard Listed biopharmaceutical group developing therapies...
LONDON, UK / ACCESSWIRE / September 30, 2020 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the Standard Listed biopharmaceutical group developing therapies...